EVIDA
Live / Allowed — Third extension granted (statement of use) (as of 23 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Oct 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98207152
- Mark type
- Word mark
- Filed
- 02 Oct 2023
- Published for opposition
- 19 Nov 2024
- Attorney of record
- Kelley B. Harrington
Goods and services
- Class 042 — Scientific and technological services: Medical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases
Owner
- Prometheus Laboratories, Inc., San Diego, CA, US
- Prometheus Laboratories, Inc., San Diego, CA, US
Prosecution history
- 23 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2026 — SOU EXTENSION 3 GRANTED
- 22 Jun 2026 — SOU EXTENSION 3 FILED
- 22 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 2 GRANTED
- 16 Dec 2025 — SOU EXTENSION 2 FILED
- 16 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2025 — SOU EXTENSION 1 GRANTED
- 14 Jan 2025 — SOU EXTENSION 1 FILED
- 14 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION